Focus: Profound Medical is a medical device company specializing in real-time MRI-guided therapeutic systems, focused on oncology applications. The company is a publicly-traded mid-cap biotech with a narrow but innovative product focus centered on prostate cancer interventions.
Profile data last refreshed 4h ago · AI intelligence enriched 2w ago
Cooling — net -5 jobs in 30d
7 added, 12 removed. Slower than typical.
Best fit for early-stage medical device professionals seeking exposure to a commercializing oncology technology with meaningful cash runway but elevated execution risk.
Flagship minimally-invasive platform combining real-time MRI guidance with ultrasound ablation; primary driver of commercial expansion and clinical validation efforts.
Help build intelligence for Profound Medical
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Profound Medical's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Based on last 4 crawl cycles
Source: USCIS H-1B Employer Data Hub
Recent peer-reviewed publications with author affiliations at this company
Automated subcutaneous fat segmentation with a convolutional neural network in magnetic resonance guided high-intensity focused ultrasound treatment for uterine fibroids.
Saline Displacement of Rectal Wall for Improved Margin During MRI-Guided Transurethral Ultrasound Ablation (TULSA).
Showing 5 of 10 publications
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo